JournalTOCs

Expert Opinion on Therapeutic Patents
Journal Prestige (SJR): 0.926

Citation Impact (citeScore): 3
Number of Followers: 8

Hybrid journal * Containing 1 Open Access article(s) in this issue *
ISSN (Print) 1354-3776 - ISSN (Online) 1744-7674
Published by Taylor and Francis

[2652 journals]

CDC7 kinase inhibitors: a survey of recent patent literature
(2017–2022)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Takayuki IrieMasaaki SawaDrug Discovery; Development, Carna Biosciences, Inc, Kobe, Japan
  Pages: 1 - 9
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2023-09-22T05:47:41Z
  DOI: 10.1080/13543776.2023.2262138
An updated patent review of metallo-β-lactamase inhibitors
(2020–2023)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Elsa DenakpoThierry NaasBogdan I. Iorgaa Université Paris-Saclay; CNRS, Institut de Chimie des Substances Naturelles, Gif-sur-Yvette, Franceb Team ReSIST, INSERM U1184, School of Medicine Université Paris-Saclay, LabEx LERMIT, Le Kremlin-Bicêtre, Francec Bacteriology-Hygiene unit, Assistance Publique/Hopitaux de Paris, Bicêtre Hospital, Le Kremlin-Bicêtre, Franced French National Reference Center for Antibiotic Resistance: Carbapenemase-producing Enterobacterales, Le Kremlin-Bicêtre, France
  Pages: 1 - 16
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2023-09-22T02:43:15Z
  DOI: 10.1080/13543776.2023.2262763
Targeting carbonic anhydrases for the management of hypoxic metastatic
tumors
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Claudiu T Supuran; Pharmaceutical Nutraceutical Section, University of Florence, Sesto Fiorentino, Firenze, Italy()
  Pages: 1 - 20
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2023-08-12T09:44:43Z
  DOI: 10.1080/13543776.2023.2245971
Patent landscape highlighting therapeutic implications of peptides
targeting myristoylated alanine-rich protein kinase-C substrate (MARCKS)
Open Access Article
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Vikas Yadav, Amarish Kumar Sharma, Gaurav Parashar, Nidarshana Chaturvedi Parashar, Seema Ramniwas, Manoj Kumar Jena, Hardeep Singh Tuli, Kiran Yadav; Clinical Research Centre, Skane University Hospital, Malmö, Swedenb Department of Biotechnology, School of Bioengineering & Biosciences, Lovely Professional University, Phagwara, Punjab, Indiac Division of Biomedical & Life Sciences, School of Science, Navrachana University, Vadodara, Gujarat, Indiad Department of Bio-Sciences Technology, Maharishi Markandeshwar Engineering College, Maharishi Markandeshwar (Deemed to Be University), Ambala, Haryana, Indiae University Centre for Research & Development, University Institute of Pharmaceutical Sciences, Chandigarh University, Gharuan, Mohali, Punjab, Indiaf Chandigarh College of Pharmacy, Chandigarh Group of Colleges, Mohali, Punjab, India
  Pages: 1 - 10
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2023-08-01T08:45:55Z
  DOI: 10.1080/13543776.2023.2240020
A patent review of MAPK inhibitors (2018 – present)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Valentin R Wydra, Raphael B Ditzinger, Nico J Seidler, Frederik W Hacker, Stefan A Laufer; Medicinal Chemistry, Eberhard Karls Universit’t Tübingen, Tübingen, Germanyb Cluster of Excellence iFIT (EXC2180) “Image-Guided & Functionally Instructed Tumor Therapies”, Eberhard Karls Universität Tübingen, Tübingen, Germanyc Tübingen Center for Academic Drug Discovery & Development (Tücad2), Tübingen, Germany
  Pages: 1 - 24
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2023-08-01T01:46:25Z
  DOI: 10.1080/13543776.2023.2242584
Proteolysis-Targeting Chimeras (PROTACs) targeting the BCR-ABL for the
treatment of chronic myeloid leukemia – a patent review
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: André T. S. Vicente, Jorge A.R. Salvador; Faculty of Pharmacy, University of Coimbra, Coimbra, Portugalb Center for Neuroscience Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal
  Pages: 1 - 24
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2023-07-26T03:33:26Z
  DOI: 10.1080/13543776.2023.2240025
A patent review of NLRP3 inhibitors to treat autoimmune diseases
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Yiming Xu, Savannah Biby, Baljit Kaur, Shijun Zhang; Virginia Commonwealth University, Richmond, VA, USA
  Pages: 1 - 16
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2023-07-26T03:31:37Z
  DOI: 10.1080/13543776.2023.2239502